This is a $8,471.66 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract has an ultimate completion date of January 24, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,138.04 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a prescription medication. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the agency's ECAT Generation V Program. This single-award IDC allows the company to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract has a ceiling value of $2,252.99 and a performance period through December 18, 2023. Dakota Drug, Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,179.50, is for the delivery of Eliquis 5 mg tablets to support U.S. Armed Forces medical operations. The contract is a firm-fixed-price arrangement with an ultimate completion date of October 31, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of...
The Defense Logistics Agency (DLA) awarded a $8,647.68 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Eliquis 5 mg tablets. This contract does not have a set-aside designation. Dakota Drug, Inc. is a prime contractor to the DLA Troop Support Medical and holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the agency under the ECAT Generation V Program, which allows the company to provide a wide range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $14,529.07 firm fixed-price contract is for the delivery of Eliquis 5 mg tablets to support U.S. military medical operations. The contract is not set-aside and has an ultimate completion date of April 27, 2023. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the delivery of Eliquis 5 mg tablets. The contract, valued at $10,949.56, has a firm fixed price and an ultimate completion date of December 4, 2024. Dakota Drug, Inc. is the prime contractor, and there are no major subcontractors mentioned. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which is an Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,361.85 contract is for the supply of Eliquis 5 mg tablets, a prescription medication used to treat and prevent blood clots. This contract is issued under Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which allows the company to provide a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,674.18 and a performance period ending on January 4, 2023. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001 and valued at $999,999,999.00, as part of the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,909.62, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a period of performance through January 24, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued...